Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are studying patients with atrial fibrillation AF who have experienced a recent ischemic stroke to see if adding bilateral carotid filter implants to oral anticoagulation OAC therapy can reduce the risk of another stroke. Despite OAC treatment, these patients face a high chance of recurrent strokes, especially from large emboli causing large vessel occlusions LVO. The study aims to address this unmet need by evaluating the effectiveness and safety of these carotid filters in preventing strokes. Participants will be randomly assigned to one of two groups one group will receive the bilateral carotid filter implants plus OAC and a single antiplatelet therapy for six months, while the control group will receive standard care with OAC alone. The filters are implanted in the common carotid arteries to capture larger emboli before they reach the brains anterior circulation. The study will monitor stroke occurrences, device-related complications, and bleeding events over a period of up to 44 months. During the study, participants will be closely monitored for strokes caused by large vessel occlusion, overall ischemic strokes, and any serious complications related to the device or procedure. Safety assessments include tracking major bleeding events while on combined therapy. Researchers will collect data through imaging and clinical evaluations throughout the study duration, which may last until October 2030. The primary goal is to determine if carotid implants can safely reduce disabling strokes in this high-risk group.